Skip to content
Research Article Open access CC BY 4.0

Diabetes Mellitus: Can Stem Cells be the Answer?

M. Senthilnathan, A. Ramadevi, K. x K. Srinivas, A. Thangamani

Biotechnology Journal International · pp. 1–12 · Published 18 Jul 2017

10.9734/BJI/2017/34614

Abstract

This review aims to enlighten the readers regarding the past, present and future of stem cells in the treatment of Diabetes. Diabetes is one of the leading causes of morbidity and mortality, affecting more than 415 million people worldwide.  It is estimated that one in ten adults will have diabetes by 2030. Diabetes is mainly due to reduction in β-cell mass which are responsible for insulin production. Exogenous administration of insulin is having good impact on restoring glucose homeostasis, but it does not entirely control the minute-to-minute fluctuations in systemic blood glucose. Recently cellular-based therapies have been established for exogenous insulin administration by modern pump technology. One of the most interesting therapies involves substitution of insulin producing islet cells by transplantation. But lack of donor material and lifelong immunosuppression made the technique unfeasible. These restrictions have led to exploration of other sources of β-cells, one of the prospects being the stem cells. Several types of stem cells have been used to make pancreatic β-cells, including human embryonic stem cells / induced pluripotent stem cells, pancreatic stem / progenitor cells, and non-pancreatic stem cells. There is also evidence of adult β-cells regeneration through β-cell replication and cellular reprogramming. Functional restoration of existing β-cells, transplantation of stem cells or stem cell-derived β-like cells might provide new opportunities for treatment. In conclusion it can be said that the research is still wide open to arrive at the efficient reprogramming of various types of stem cells to destine them towards functional β-cells.

Diabetes Mellitus β-cell of pancreas stem cell therapy pluripotent stem cells differentiation

References (93)

  1. 1 Mechanisms linking obesity to insulin resistance and type 2 diabetes [DOI]
  2. 2 Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA [DOI]
  3. 3 Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences [DOI]
  4. 4 Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells [DOI]
  5. 5 Stem Cells [DOI]
  6. 6 Efficient differentiation of human embryonic stem cells to definitive endoderm [DOI]
  7. 7 Induced Pluripotent Stem Cells Generated Without Viral Integration [DOI]
  8. 8 Genetics, pathogenesis and clinical interventions in type 1 diabetes [DOI]
  9. 9 Control of endodermal endocrine development by Hes-1 [DOI]
  10. 10 Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells [DOI]
  11. 11 Bone marrow–derived stem cells initiate pancreatic regeneration [DOI]
  12. 12 Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. [DOI]
  13. 13 Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages [DOI]
  14. 14 Induced Pluripotent Stem Cell Lines Derived From Human Somatic Cells [DOI]
  15. 15 The Vascular Basement Membrane: A Niche for Insulin Gene Expression and β Cell Proliferation [DOI]
  16. 16 Islet Transplantation as a Treatment for Diabetes — A Work in Progress [DOI]
  17. 17 Small Molecules Efficiently Direct Endodermal Differentiation of Mouse and Human Embryonic Stem Cells [DOI]
  18. 18 An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells [DOI]
  19. 19 Functional beta-cell maturation is marked by an increased glucose threshold and by expression of urocortin 3 [DOI]
  20. 20 Generation of Insulin-secreting Islet-like Clusters from Human Skin Fibroblasts [DOI]
  21. 21 Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells [DOI]
  22. 22 In vitro derivation of functional insulin-producing cells from human embryonic stem cells [DOI]
  23. 23 Extracellular Matrix in Pancreatic Islets: Relevance to Scaffold Design and Transplantation [DOI]
  24. 24 In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells [DOI]
  25. 25 Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells [DOI]
  26. 26 Type 1 Diabetes Mellitus in Pediatrics [DOI]
  27. 27 Mesenchymal Stem Cell and Islet Co-Transplantation Promotes Graft Revascularization and Function [DOI]
  28. 28 Direct lineage tracing reveals the ontogeny of pancreatic cell fates during mouse embryogenesis [DOI]
  29. 29 Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells [DOI]
  30. 30 Stem cell therapy for type 1 diabetes mellitus [DOI]
  31. 31 Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny [DOI]
  32. 32 Current Status of Islet Cell Replacement and Regeneration Therapy [DOI]
  33. 33 Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus [DOI]
  34. 34 Pancreas Transplantation: Indications and Consequences [DOI]
  35. 35 Evidence for a circulating islet cell growth factor in insulin-resistant states [DOI]
  36. 36 Failure of Transplanted Bone Marrow Cells to Adopt a Pancreatic β-Cell Fate [DOI]
  37. 37 Identification of small-molecule inducers of pancreatic β-cell expansion [DOI]
  38. 38 Exendin-4 Promotes Liver Cell Proliferation and Enhances the PDX-1-induced Liver to Pancreas Transdifferentiation Process [DOI]
  39. 39 Regulation of β‐cell mass and function by the Akt/protein kinase B signalling pathway [DOI]
  40. 40 Matrix Components and Scaffolds for Sustained Islet Function [DOI]
  41. 41 Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells [DOI]
  42. 42 Plasticity of Adult Human Pancreatic Duct Cells by Neurogenin3-Mediated Reprogramming [DOI]
  43. 43 Adenovirus-based vascular endothelial growth factor gene delivery to human pancreatic islets [DOI]
  44. 44 Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established [DOI]
  45. 45 Lineage tracing and resulting phenotype of haemopoietic-derived cells in the pancreas during beta cell regeneration [DOI]
  46. 46 Postnatal Histogenesis of Islets of Langerhans in Rat
  47. 47 Stem Cells and Diabetes [DOI]
  48. 48 International Handbook of Pancreas Transplantation [DOI]
  49. 49 International Handbook of Pancreas Transplantation [DOI]
  50. 50 ELEVATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION AND ITS EFFECT ON REVASCULARIZATION AND FUNCTION OF GRAFT ISLETS IN DIABETIC RATS [DOI]
  51. 51 Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors [DOI]
  52. 52 International Diabetes Federation 2017 [DOI]
  53. 53 Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells [DOI]
  54. 54 Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen [DOI]
  55. 55 In vivo reprogramming of adult pancreatic exocrine cells to β-cells [DOI]
  56. 56 Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo [DOI]
  57. 57 Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins [DOI]
  58. 58 Five-Year Follow-Up After Clinical Islet Transplantation [DOI]
  59. 59 Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors [DOI]
  60. 60 Standards of Medical Care in Diabetes 2014 [DOI]
  61. 61 Virus-free induction of pluripotency and subsequent excision of reprogramming factors [DOI]
  62. 62 Conversion of adult pancreatic α-cells to β-cells after extreme β-cell loss [DOI]
  63. 63 Five Stages of Evolving Beta-Cell Dysfunction During Progression to Diabetes [DOI]
  64. 64 In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion [DOI]
  65. 65 Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia [DOI]
  66. 66 Generation of pluripotent stem cells from patients with type 1 diabetes [DOI]
  67. 67 A small molecule that directs differentiation of human ESCs into the pancreatic lineage [DOI]
  68. 68 C-Peptide Levels and Insulin Independence Following Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus [DOI]
  69. 69 Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth [DOI]
  70. 70 Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells [DOI]
  71. 71 Diabetes [DOI]
  72. 72 Survival After Pancreas Transplantation in Patients With Diabetes and Preserved Kidney Function [DOI]
  73. 73 Diabetes Mellitus Review [DOI]
  74. 74 Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes [DOI]
  75. 75 Regulation of the Pancreatic Pro-Endocrine Gene Neurogenin3 [DOI]
  76. 76 Prospective Isolation of Multipotent Pancreatic Progenitors Using Flow-Cytometric Cell Sorting [DOI]
  77. 77 PDX-1/VP16 Fusion Protein, Together With NeuroD or Ngn3, Markedly Induces Insulin Gene Transcription and Ameliorates Glucose Tolerance [DOI]
  78. 78 Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins [DOI]
  79. 79 A Small Molecule Primes Embryonic Stem Cells for Differentiation [DOI]
  80. 80 Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia [DOI]
  81. 81 Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replication [DOI]
  82. 82 Effects of meal and incretins in the regulation of splanchnic blood flow [DOI]
  83. 83 Elevation of vascular endothelial growth factor production and its effect on revascularization and function of graft islets in diabetic rats [DOI]
  84. 84 Pancreatic Inflammation Redirects Acinar to β Cell Reprogramming [DOI]
  85. 85 In Vitro Epithelial Differentiation of Human Induced Pluripotent Stem Cells for Vocal Fold Tissue Engineering [DOI]
  86. 86 Hematopoietic Stem Cells Derived From Adult Donors Are Not a Source of Pancreatic β-Cells in Adult Nondiabetic Humans [DOI]
  87. 87 Identification of Hematopoietic Stem Cell Engraftment Genes in Gene Therapy Studies [DOI]
  88. 88 The contribution of hematopoietic stem cells to beta-cell replacement [DOI]
  89. 89 Turning Human Epidermis Into Pancreatic Endoderm [DOI]
  90. 90 Survival After Pancreas Transplantation in Patients With Diabetes and Preserved Kidney Function [DOI]
  91. 91 Springer Science and Business Media
  92. 92 Embryonic stem cell differentiation: emergence of a new era in biology and medicine [DOI]
  93. 93 Regulation of beta-cell mass by hormones and growth factors. [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

62

Page views

0

PDF downloads

36

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.